ÌÇÐÄÆƽâ°æ

Share of Pfizer/BioNTech COVID-19 vaccines delivered worldwide as of September 2021, by country income group

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

September 2021

Region

Worldwide

Survey time period

as of September 6, 2021

Citation formats

Pfizer/BioNTech COVID-19 vaccines delivered by country income group 2021

Published by A. Minhas, Nov 12, 2021
As of ****, high-income countries accounted for around ** percent of total Pfizer/BioNTech vaccines delivered worldwide. The statistic illustrates the share of Pfizer/BioNTech COVID-19 vaccines delivered worldwide as of ****, by country income group.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus (COVID-19): vaccines and vaccination campaign "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19): vaccines and vaccination campaign

Pandemic situation

5

Search for vaccines

7

Leading products and companies

7

Vaccination campaign

5

Vaccination approval and willingness

8

Distribution inequality

5

Further Content: You might find this interesting as well

Topics

BioNTechBiotech drugs worldwidemRNA technologyCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.